Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa.

Autor: Dixon, Laura, Bartel, Sara, Brown, Victoria, Ali, Sarrah I., Gamberg, Susan, Murphy, Andrea, Brewer, Katherine L., McElroy, Susan L., Kaplan, Allan, Nunes, Abraham, Keshen, Aaron R.
Předmět:
Zdroj: Journal of Eating Disorders; 11/16/2023, Vol. 11 Issue 1, p1-1, 1p
Abstrakt: This correction notice is for an article titled "Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa" published in the Journal of Eating Disorders. The correction addresses incomplete funding information, specifically the sponsorship from Takeda Pharmaceutical Australia to cover the Article Processing Charge, which was not mentioned in the original article's Funding note. The correct Funding note is provided in the correction notice. The publisher, Springer Nature, maintains neutrality regarding jurisdictional claims and institutional affiliations. [Extracted from the article]
Databáze: Complementary Index
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje